Other Events ·
Nasdaq notifies DataMeds AI of regained compliance with $2.5M minimum stockholders' equity listing rule
MEDSDataMeds AI, Inc.
DataMeds AI, Inc. has received written notice from Nasdaq confirming it has regained compliance with Listing Rule 5550(b)(1), which requires a minimum stockholders’ equity of $2.5 million. The company previously received a deficiency letter on April 13, 2026, citing negative equity of $(12,447,801) and failure to meet alternative standards. While the company had already regained bid-price compliance in June 2026, this notice resolves the equity requirement. The filing notes that failure to evidence compliance upon filing its next periodic report may result in delisting proceedings. DataMeds AI operates as a healthcare technology company integrating Health IT platforms, pharmacy services, and artificial intelligence solutions.